Sutton Wealth Advisors Inc. Halozyme Therapeutics, Inc. Transaction History

Sutton Wealth Advisors Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$32.86 - $55.7 $460 - $779	-14 Closed	0 $0
Q3 2022 Nov 07, 2023	SELL	$38.53 - $51.78 $500 - $673	-13 Reduced 48.15%	14 $554,000
Q2 2022 Nov 07, 2023	SELL	$37.35 - $48.3 $149 - $193	-4 Reduced 12.9%	27 $1.19 Million
Q1 2022 Nov 07, 2023	BUY	$31.97 - $41.06 $447 - $574	14 Added 82.35%	31 $1.24 Million
Q4 2021 Nov 07, 2023	BUY	$31.82 - $40.75 $540 - $692	17 New	17 $684,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.